Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1269.80
-78.90 (-5.85%)
< Home < Back

Dr. Reddys Laboratories reports 26% rise in Q2 consolidated net profit

Date: 30-10-2015

Dr. Reddys Laboratories has reported results for second quarter ended September 30, 2015.

The company has reported 49.34% rise in its net profit at Rs 647.52 crore for the quarter ended September 30, 2015 as compared to Rs 433.59 crore for the same quarter in the previous year. The company’s total income has increased by 16.57% to Rs 2955.83 crore for the quarter under review from Rs 2535.62 crore for the corresponding quarter of the previous year.

On the consolidated basis, the company has reported 25.74% rise in its net profit after taxes and minority interest at Rs 721.89 crore for the quarter ended September 30, 2015 as compared to Rs 574.10 crore for the same quarter in the previous year. Total income of the company has increased by 11.25% at Rs 4020.95 crore for quarter under review as compared to Rs 3614.37crore for the quarter ended September 30, 2014.